CanBas Co., Ltd. (TYO:4575)
Japan · Delayed Price · Currency is JPY 747.00
+18.00 (2.47%)
Mar 27, 2026, 3:30 PM JST
CanBas Market Cap
CanBas has a market cap or net worth of 14.28 billion as of March 27, 2026. Its market cap has decreased by -29.40% in one year.
Market Cap
14.28B
Enterprise Value
12.08B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
747.00
Market Cap Chart
Since September 18, 2009, CanBas's market cap has increased from 8.38B to 14.28B, an increase of 70.31%. That is a compound annual growth rate of 3.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 14.28B | -6.97% |
| Dec 30, 2025 | 15.35B | -10.38% |
| Dec 30, 2024 | 17.13B | 0.65% |
| Dec 29, 2023 | 17.01B | -5.30% |
| Dec 30, 2022 | 17.97B | 974.22% |
| Dec 30, 2021 | 1.67B | -48.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Renascience | 23.31B |
| RaQualia Pharma | 21.57B |
| StemRIM | 18.99B |
| ReproCELL | 17.33B |
| Immuno-Biological Laboratories | 12.96B |
| Kidswell Bio | 12.45B |
| Nano Holdings | 12.36B |
| Kubota Pharmaceutical Holdings | 11.77B |